| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 11/09/2024 | 17:57 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:JAN | JanOne Inc |
| 30/08/2024 | 19:47 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:JAN | JanOne Inc |
| 29/08/2024 | 03:59 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:JAN | JanOne Inc |
| 23/08/2024 | 20:44 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:JAN | JanOne Inc |
| 19/08/2024 | 22:29 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:JAN | JanOne Inc |
| 13/08/2024 | 16:55 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | NASDAQ:JAN | JanOne Inc |
| 13/07/2024 | 00:41 | PR Newswire (US) | JANONE CONFIRMS NAME CHANGE TO ALT5 SIGMA CORPORATION AND NEW TICKER SYMBOL TO ALTS | NASDAQ:JAN | JanOne Inc |
| 10/07/2024 | 14:30 | PR Newswire (US) | JanOne Announces Plan to Enhance Stockholder Value Through Strategic Realignment | NASDAQ:JAN | JanOne Inc |
| 26/06/2024 | 13:30 | PR Newswire (US) | JanOne Appoints Vay Tham as its Chief Revenue Officer and President of its Fintech Subsidiary, ALT5 Sigma | NASDAQ:JAN | JanOne Inc |
| 25/06/2024 | 13:30 | PR Newswire (US) | ALT5 SIGMA, A JANONE COMPANY, ADDS PREPAID VISA®️ CARD INTEGRATION TO ALT5 SETTLEMENT PLATFORM | NASDAQ:JAN | JanOne Inc |
| 13/06/2024 | 13:30 | PR Newswire (US) | JanOne's Subsidiary, Alt5, Reports 91% year over year increase in Transaction Volume to US $289 million for April and May 2024 | NASDAQ:JAN | JanOne Inc |
| 11/06/2024 | 14:30 | PR Newswire (US) | ALT5 Sigma, a wholly-owned subsidiary of JanOne, Launches ALT5 Settlement Platform aimed at the untapped $27.3 Billion Global Digital Content Creation Market | NASDAQ:JAN | JanOne Inc |
| 05/06/2024 | 21:50 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | NASDAQ:JAN | JanOne Inc |
| 03/06/2024 | 18:05 | PR Newswire (US) | JanOne Inc. added to the Russell Microcap® Index | NASDAQ:JAN | JanOne Inc |
| 16/05/2024 | 22:00 | PR Newswire (US) | JanOne Closes Acquisition of ALT 5 Sigma Inc., a Leading Next Generation Blockchain Fintech | NASDAQ:JAN | JanOne Inc |
| 13/05/2024 | 13:30 | PR Newswire (US) | JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology Provider | NASDAQ:JAN | JanOne Inc |
| 15/03/2024 | 14:00 | PR Newswire (US) | JanOne Regains Compliance with Nasdaq's Listing Requirements | NASDAQ:JAN | JanOne Inc |
| 21/09/2023 | 17:30 | PR Newswire (US) | JanOne to Present at the Dawson James 8th Annual Investment Conference | NASDAQ:JAN | JanOne Inc |
| 21/09/2023 | 15:35 | GlobeNewswire Inc. | Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference | NASDAQ:JAN | JanOne Inc |
| 31/08/2023 | 19:30 | PR Newswire (US) | JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference | NASDAQ:JAN | JanOne Inc |
| 29/08/2023 | 19:30 | PR Newswire (US) | JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain | NASDAQ:JAN | JanOne Inc |
| 28/08/2023 | 23:20 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:JAN | JanOne Inc |
| 25/08/2023 | 20:30 | PR Newswire (US) | JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting | NASDAQ:JAN | JanOne Inc |
| 24/08/2023 | 22:30 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:JAN | JanOne Inc |
| 22/08/2023 | 23:30 | PR Newswire (US) | JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules | NASDAQ:JAN | JanOne Inc |
| 19/08/2023 | 01:00 | PR Newswire (US) | JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules | NASDAQ:JAN | JanOne Inc |
| 18/08/2023 | 18:42 | PR Newswire (US) | JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting | NASDAQ:JAN | JanOne Inc |
| 16/08/2023 | 21:55 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements | NASDAQ:JAN | JanOne Inc |
| 28/06/2023 | 14:30 | PR Newswire (US) | JanOne files international patent application for methods of using low dose naltrexone to treat chronic pain | NASDAQ:JAN | JanOne Inc |
| 22/05/2023 | 22:32 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:JAN | JanOne Inc |
